Morganella morganii

Associated infections

• Urinary tract infection, frequently catheter-associated
• Bloodstream infection and sepsis
• Surgical site, wound and soft tissue infection
• Hepatobiliary and intra-abdominal infection
• Hospital-acquired pneumonia
• Neonatal sepsis and, rarely, meningitis

Transmission route

The gastrointestinal tract is the primary reservoir. In healthcare settings, spread occurs through contaminated hands, contaminated equipment and contact with body fluids, most often in patients whose intestinal flora has been altered by antimicrobial therapy. Person-to-person and device-mediated transmission are both documented; M. morganii is not primarily an airborne or waterborne organism, and its appearance in a water sample should not be interpreted through the same lens as a genuine water organism.

As with other Enterobacterales, wet sanitary infrastructure functions as a secondary reservoir. Drains, P-traps, sink surrounds and macerator or disposal areas support persistent Gram-negative populations, and splash and aerosol generated at those points can transfer organisms onto adjacent surfaces. In a reprocessing room this becomes a defined risk where clean-side benches, drying racks, storage cabinet openings or water sampling ports sit within splash range of a sink, or where the same staff movement pattern connects a disposal point to a clean handling step without an intervening hand hygiene opportunity.

Morganella morganii is not part of the expected microbial flora of a purified or treated water system and is not anticipated in endoscope final rinse water. Its recovery from rinse water, washer-disinfector water or a patient-ready endoscope indicates a defect in the reprocessing pathway and should trigger source investigation rather than a simple resample. Plausible pathways include carry-over of patient-derived bioburden due to incomplete manual cleaning or brushing of channels, cross-contamination between contaminated and clean zones or between handling steps, contamination introduced at the point of use downstream of water treatment, and colonisation of biofilm within distribution pipework or endoscope lumens. Like other Enterobacterales, M. morganii can be incorporated into mixed-species biofilm on wetted surfaces, where extracellular polymeric matrix limits disinfectant penetration. Retained moisture in endoscope channels during storage is a recognised driver of persistent contamination and should be assessed as part of any investigation.

Relevance in endoscopy and reprocessing

There is no substantial published literature implicating Morganella morganii as a cause of endoscopy-associated outbreaks, and it should not be presented as an established endoscope-transmitted pathogen. The organisms with a documented record in flexible endoscope transmission are principally Pseudomonas aeruginosa, carbapenemase-producing Enterobacterales including Klebsiella pneumoniae and Escherichia coli, Salmonella species and mycobacteria. M. morganii belongs to the same order as several of those organisms and shares their reprocessing behaviour, but the specific incident evidence for this species is absent. Stating that plainly is more useful to an infection-control reader than implying a risk profile the evidence does not support.

What the organism does share with the wider Enterobacterales group is directly applicable. It is a routine constituent of gastrointestinal bioburden and is therefore introduced onto gastroscopes, colonoscopes and duodenoscopes at every relevant procedure. It has no intrinsic tolerance of the disinfectant chemistries used for high-level disinfection and is reliably inactivated by validated aldehyde, peracetic acid and oxidising processes, and by thermal disinfection at standard parameters. It can, however, participate in mixed-species biofilm within suction and biopsy channels, air and water lines, elevator mechanisms and washer-disinfector rinse circuits, and once embedded it is protected by the same physical mechanisms that shield other Gram-negative organisms: restricted diffusion through the polymeric matrix, chemical quenching by matrix and residual soil, and reduced metabolic activity in deeper layers.

The practical implication is that recovery of M. morganii from a reprocessed endoscope or from final rinse water is a marker of process failure in a device whose duty cycle guarantees enteric exposure. The investigation should address the steps that determine whether patient bioburden is removed and whether the device stays clean afterwards: point-of-use pre-clean timeliness, leak testing, manual brushing of every accessible channel with correctly sized brushes, connector and valve reprocessing, cycle parameter verification, final rinse water quality, and channel drying before storage. Because the organism cannot multiply without free water, verified drying is a disproportionately effective control, and a wet-storage practice will amplify a small reprocessing failure into a clinically meaningful load.

Interpreting a detection

A Morganella result in a water or final rinse sample is best interpreted as evidence that enteric material has reached a pathway where it does not belong. The organism is not an environmental water specialist, so unlike a Sphingomonas or Methylobacterium detection it does not point primarily at loop stagnation or filtration performance. It points at a route by which patient-derived or drainage-derived contamination has entered the clean side. That framing determines where the investigation should start.

First, test the artefact hypotheses. Sampling technique is the leading alternative explanation: an outlet not disinfected before sampling, a bottle opened near a sink or in a splash zone, a gloveless hand on the sampling port, or a sample drawn immediately after handling contaminated equipment can each introduce Enterobacterales that were never present in the water. Establish who sampled, at which point, using what preparation, and whether other samples from the same round or the same operator show related organisms. Second, confirm the identification method, since Morganella can be confused with Proteus and Providencia on limited biochemical panels; ask whether MALDI-TOF or molecular confirmation was used and request that the isolate be retained for comparison if a second detection follows. Third, review the concurrent total viable count and the endotoxin result where one is available, because a specific Gram-negative identification in the context of an otherwise unremarkable TVC has a different meaning from the same identification alongside a count trending upward over several rounds.

A single confirmed isolate with sound technique warrants a documented investigation and a targeted repeat sample from the same outlet plus at least one upstream point, so that the result can be localised to the point of use or attributed to the distribution system. Repeat detection, or detection accompanied by TVC drift, moves the finding from event to system status and justifies withholding the affected reprocessor or outlet from patient-ready work until remediated. The review list should cover physical workflow separation between contaminated and clean zones; sink, drain and disposal-point placement relative to clean surfaces and sampling points; backflow prevention at the reprocessor water connection and its verification status; condition and age of flexible inlet hoses and fittings; filter housing integrity and filter change records; sanitisation regime, contact time and temperature; the presence of dead legs and low-flow branches where an enteric organism could establish once introduced; and manual cleaning and drying compliance, including brush sizing, channel access and forced-air drying verification.

Escalate to infection prevention on any confirmed Enterobacterales isolate from final rinse water. Escalate further, involving the water treatment provider and clinical leadership, on repeat detection, on high counts, or on any recovery from a patient-ready device rather than water alone. In the latter case a documented look-back assessment of patients processed with the affected equipment should be considered, in line with local policy. Verification of remediation requires clear results from multiple sampling rounds and from more than one sampling point, not a single clean repeat.

Antimicrobial resistance

Morganella morganii possesses a chromosomal inducible AmpC beta-lactamase, conferring intrinsic resistance to penicillins, aminopenicillins, first- and second-generation cephalosporins and cefoxitin, and predisposing to derepression-associated failure of third-generation cephalosporins. It is also intrinsically resistant to colistin and to tigecycline, an important point because both agents are sometimes reached for empirically in multidrug-resistant Gram-negative infection, and misidentification of the organism can therefore produce a directly harmful treatment choice.

Acquired resistance is common. Reported clinical series show high rates of resistance to ampicillin-sulbactam, and appreciable resistance to fluoroquinolones and trimethoprim-sulfamethoxazole, mediated in part by plasmids, transposons, integrons and insertion sequences. Carbapenem-resistant isolates are described but remain uncommon. The mobile genetic elements involved are shared across the Enterobacterales, so an M. morganii isolate carrying acquired determinants is also of interest as an indicator of the wider resistance ecology of the unit from which it came.

None of these mechanisms has any bearing on the efficacy of validated cleaning, thermal disinfection or high-level chemical disinfection. Antimicrobial resistance operates through specific molecular interactions with specific drug targets, whereas reprocessing chemistries act non-specifically and simultaneously on membranes, proteins and nucleic acids, and thermal disinfection acts by denaturation. There is no established route by which beta-lactamase production, efflux upregulation or target modification would confer survival advantage against a correctly delivered high-level disinfection cycle. Survival in a reprocessing pathway is instead explained by failure of delivery: biofilm matrix, retained organic soil, inadequate channel contact, incorrect connector use, or recontamination after disinfection from rinse water or wet storage. Where a resistant isolate is recovered, the appropriate response is a lower escalation threshold on account of the clinical consequence of transmission, combined with the same physical remediation that any Enterobacterales detection would prompt.